ERS1802705 SAMEA104143687 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143687 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.033_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.033 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.033_H3K27ac ERS1802706 SAMEA104143688 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143688 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.033_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.033 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.033_H3K27me3 ERS1802707 SAMEA104143689 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143689 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.033_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.033 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.033_H3K4me1 ERS1802708 SAMEA104143690 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143690 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.033_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.033 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.033_H3K4me3 ERS1802709 SAMEA104143691 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143691 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.033_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.033 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.033_H3K9me3 ERS1802710 SAMEA104143692 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143692 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.033_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.033 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.033_input ERS1802711 SAMEA104143693 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143693 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.037_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.037 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.037_H3K27ac ERS1802712 SAMEA104143694 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143694 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.037_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.037 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.037_H3K27me3 ERS1802713 SAMEA104143695 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143695 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.037_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.037 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.037_H3K4me1 ERS1802714 SAMEA104143696 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143696 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.037_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.037 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.037_H3K4me3 ERS1802715 SAMEA104143697 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143697 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.037_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.037 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.037_H3K9me3 ERS1802716 SAMEA104143698 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143698 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.037_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.037 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.037_input ERS1802717 SAMEA104143699 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143699 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:39Z INSDC status public Submitter Id E-MTAB-5632:1.03_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.03 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.03_H3K27ac ERS1802718 SAMEA104143700 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143700 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.03_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.03 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.03_H3K27me3 ERS1802719 SAMEA104143701 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143701 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.03_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.03 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.03_H3K4me1 ERS1802720 SAMEA104143702 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143702 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.03_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.03 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.03_H3K4me3 ERS1802721 SAMEA104143703 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143703 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.03_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.03 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.03_H3K9me3 ERS1802722 SAMEA104143704 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143704 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.03_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.03 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.03_input ERS1802723 SAMEA104143705 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143705 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.042_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.042 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.042_H3K27ac ERS1802724 SAMEA104143706 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143706 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.042_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.042 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.042_H3K4me1 ERS1802725 SAMEA104143707 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143707 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.043_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.043 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.043_H3K27ac ERS1802726 SAMEA104143708 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143708 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.043_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.043 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.043_H3K4me1 ERS1802727 SAMEA104143709 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143709 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.048_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.048 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.048_H3K27ac ERS1802728 SAMEA104143710 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143710 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.048_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.048 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.048_H3K27me3 ERS1802729 SAMEA104143711 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143711 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.048_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.048 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.048_H3K4me1 ERS1802730 SAMEA104143712 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143712 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.048_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.048 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.048_H3K4me3 ERS1802731 SAMEA104143713 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143713 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.048_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.048 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.048_H3K9me3 ERS1802732 SAMEA104143714 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143714 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.048_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.048 organism part neoplasm phenotype classical sample name E-MTAB-5632:1.048_input ERS1802733 SAMEA104143715 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143715 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.052_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.052 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.052_H3K27ac ERS1802734 SAMEA104143716 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143716 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.052_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.052 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.052_H3K27me3 ERS1802735 SAMEA104143717 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143717 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.052_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.052 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.052_H3K4me1 ERS1802736 SAMEA104143718 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143718 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.052_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.052 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.052_H3K4me3 ERS1802737 SAMEA104143719 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143719 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.052_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.052 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.052_H3K9me3 ERS1802738 SAMEA104143720 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143720 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.052_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.052 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.052_input ERS1802739 SAMEA104143721 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143721 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.053_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.053 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.053_H3K27ac ERS1802740 SAMEA104143722 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143722 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:40Z INSDC status public Submitter Id E-MTAB-5632:1.053_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.053 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.053_H3K27me3 ERS1802741 SAMEA104143723 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143723 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.053_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.053 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.053_H3K4me1 ERS1802742 SAMEA104143724 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143724 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.053_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.053 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.053_H3K4me3 ERS1802743 SAMEA104143725 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143725 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.053_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.053 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.053_H3K9me3 ERS1802744 SAMEA104143726 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143726 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.053_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.053 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.053_input ERS1802745 SAMEA104143727 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143727 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.064_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.064 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.064_H3K27ac ERS1802746 SAMEA104143728 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143728 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.064_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.064 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.064_H3K27me3 ERS1802747 SAMEA104143729 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143729 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.064_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.064 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.064_H3K4me1 ERS1802748 SAMEA104143730 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143730 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.064_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.064 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.064_H3K4me3 ERS1802749 SAMEA104143731 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143731 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.064_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.064 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.064_H3K9me3 ERS1802750 SAMEA104143732 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143732 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.064_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.064 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.064_input ERS1802751 SAMEA104143733 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143733 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.119_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.119 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.119_H3K27ac ERS1802752 SAMEA104143734 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143734 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.119_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.119 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.119_H3K27me3 ERS1802753 SAMEA104143735 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143735 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.119_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.119 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.119_H3K4me1 ERS1802754 SAMEA104143736 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143736 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.119_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.119 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.119_H3K4me3 ERS1802755 SAMEA104143737 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143737 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.119_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.119 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.119_H3K9me3 ERS1802756 SAMEA104143738 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143738 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:1.119_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 1.119 organism part neoplasm phenotype basal sample name E-MTAB-5632:1.119_input ERS1802757 SAMEA104143739 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143739 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.029_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.029 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.029_H3K27ac ERS1802758 SAMEA104143740 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143740 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.029_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.029 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.029_H3K27me3 ERS1802759 SAMEA104143741 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143741 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.029_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.029 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.029_H3K4me1 ERS1802760 SAMEA104143742 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143742 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.029_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.029 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.029_H3K4me3 ERS1802761 SAMEA104143743 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143743 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.029_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.029 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.029_H3K9me3 ERS1802762 SAMEA104143744 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143744 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.029_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.029 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.029_input ERS1802763 SAMEA104143745 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143745 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.042_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.042 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.042_H3K27me3 ERS1802764 SAMEA104143746 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143746 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.042_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.042 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.042_H3K4me3 ERS1802765 SAMEA104143747 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143747 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.042_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.042 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.042_H3K9me3 ERS1802766 SAMEA104143748 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143748 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.042_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.042 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.042_input ERS1802767 SAMEA104143749 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143749 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.045_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.045 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.045_H3K27ac ERS1802768 SAMEA104143750 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143750 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.045_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.045 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.045_H3K27me3 ERS1802769 SAMEA104143751 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143751 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.045_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.045 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.045_H3K4me1 ERS1802770 SAMEA104143752 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143752 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.045_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.045 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.045_H3K4me3 ERS1802771 SAMEA104143753 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143753 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.045_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.045 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.045_H3K9me3 ERS1802772 SAMEA104143754 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143754 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.045_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.045 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.045_input ERS1802773 SAMEA104143755 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143755 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.058_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.058 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.058_H3K27ac ERS1802774 SAMEA104143756 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143756 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.058_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.058 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.058_H3K27me3 ERS1802775 SAMEA104143757 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143757 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.058_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.058 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.058_H3K4me1 ERS1802776 SAMEA104143758 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143758 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.058_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.058 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.058_H3K4me3 ERS1802777 SAMEA104143759 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143759 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.058_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.058 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.058_H3K9me3 ERS1802778 SAMEA104143760 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143760 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.058_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.058 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.058_input ERS1802779 SAMEA104143761 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143761 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.083_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.083 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.083_H3K27ac ERS1802780 SAMEA104143762 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143762 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:41Z INSDC status public Submitter Id E-MTAB-5632:2.083_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.083 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.083_H3K27me3 ERS1802781 SAMEA104143763 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143763 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:49Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.083_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.083 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.083_H3K4me1 ERS1802782 SAMEA104143764 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143764 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.083_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.083 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.083_H3K4me3 ERS1802783 SAMEA104143765 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143765 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.083_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.083 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.083_H3K9me3 ERS1802784 SAMEA104143766 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143766 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.083_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.083 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.083_input ERS1802785 SAMEA104143767 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143767 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.087_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.087 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.087_H3K27ac ERS1802786 SAMEA104143768 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143768 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.087_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.087 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.087_H3K27me3 ERS1802787 SAMEA104143769 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143769 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.087_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.087 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.087_H3K4me1 ERS1802788 SAMEA104143770 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143770 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.087_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.087 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.087_H3K4me3 ERS1802789 SAMEA104143771 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143771 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.087_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.087 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.087_H3K9me3 ERS1802790 SAMEA104143772 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143772 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.087_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.087 organism part neoplasm phenotype classical sample name E-MTAB-5632:2.087_input ERS1802791 SAMEA104143773 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143773 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.099_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.099 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.099_H3K27ac ERS1802792 SAMEA104143774 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143774 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.099_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.099 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.099_H3K27me3 ERS1802793 SAMEA104143775 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143775 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.099_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.099 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.099_H3K4me3 ERS1802794 SAMEA104143776 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143776 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.099_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.099 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.099_H3K9me3 ERS1802795 SAMEA104143777 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143777 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.099_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.099 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.099_input ERS1802796 SAMEA104143778 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143778 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.116_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.116 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.116_H3K27ac ERS1802797 SAMEA104143779 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143779 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.116_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.116 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.116_H3K27me3 ERS1802798 SAMEA104143780 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143780 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.116_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.116 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.116_H3K4me1 ERS1802799 SAMEA104143781 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143781 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.116_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.116 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.116_H3K4me3 ERS1802800 SAMEA104143782 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143782 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.116_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.116 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.116_H3K9me3 ERS1802801 SAMEA104143783 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143783 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2.116_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.116 organism part neoplasm phenotype basal sample name E-MTAB-5632:2.116_input ERS1802802 SAMEA104143784 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143784 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:2_099_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 2.099 organism part neoplasm phenotype basal sample name E-MTAB-5632:2_099_H3K4me1 ERS1802803 SAMEA104143785 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143785 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.043_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.043 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.043_H3K27me3 ERS1802804 SAMEA104143786 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143786 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.043_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.043 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.043_H3K4me3 ERS1802806 SAMEA104143788 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143788 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.043_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.043 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.043_input ERS1802807 SAMEA104143789 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143789 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.076_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.076 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.076_H3K27ac ERS1802808 SAMEA104143790 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143790 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.076_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.076 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.076_H3K27me3 ERS1802809 SAMEA104143791 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143791 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.076_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.096 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.076_H3K4me1 ERS1802810 SAMEA104143792 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143792 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.076_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.076 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.076_H3K4me3 ERS1802811 SAMEA104143793 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143793 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.076_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.076 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.076_H3K9me3 ERS1802812 SAMEA104143794 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143794 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.076_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.076 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.076_input ERS1802813 SAMEA104143795 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143795 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AH.IP_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AM.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AH.IP_H3K27ac ERS1802814 SAMEA104143796 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143796 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AH.IP_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AH.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AH.IP_H3K27me3 ERS1802815 SAMEA104143797 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143797 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AH.IP_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AH.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AH.IP_H3K4me1 ERS1802816 SAMEA104143798 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143798 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AH.IP_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AH.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AH.IP_H3K4me3 ERS1802817 SAMEA104143799 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143799 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AH.IP_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AH.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AH.IP_H3K9me3 ERS1802818 SAMEA104143800 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143800 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AH.IP_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AH.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AH.IP_input ERS1802819 SAMEA104143801 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143801 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AM.IP_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AM.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AM.IP_H3K27ac ERS1802820 SAMEA104143802 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143802 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AM.IP_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AM.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AM.IP_H3K27me3 ERS1802821 SAMEA104143803 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143803 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AM.IP_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AM.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AM.IP_H3K4me1 ERS1802822 SAMEA104143804 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143804 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:AM.IP_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AM.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AM.IP_H3K4me3 ERS1802823 SAMEA104143805 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143805 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:AM.IP_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AM.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AM.IP_H3K9me3 ERS1802824 SAMEA104143806 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143806 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:AM.IP_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AM.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:AM.IP_input ERS1802825 SAMEA104143807 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143807 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:AO.IP_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AO.IP organism part neoplasm phenotype classical sample name E-MTAB-5632:AO.IP_H3K27ac ERS1802826 SAMEA104143808 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143808 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:AO.IP_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AO.IP organism part neoplasm phenotype classical sample name E-MTAB-5632:AO.IP_H3K27me3 ERS1802827 SAMEA104143809 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143809 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:AO.IP_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AO.IP organism part neoplasm phenotype classical sample name E-MTAB-5632:AO.IP_H3K4me1 ERS1802828 SAMEA104143810 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143810 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:AO.IP_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AO.IP organism part neoplasm phenotype classical sample name E-MTAB-5632:AO.IP_H3K4me3 ERS1802805 SAMEA104143787 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143787 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:42Z INSDC status public Submitter Id E-MTAB-5632:3.043_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual 3.043 organism part neoplasm phenotype basal sample name E-MTAB-5632:3.043_H3K9me3 ERS1802829 SAMEA104143811 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143811 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:AO.IP_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AO.IP organism part neoplasm phenotype classical sample name E-MTAB-5632:AO.IP_H3K9me3 ERS1802830 SAMEA104143812 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143812 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:AO.IPC_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual AO.IPC organism part neoplasm phenotype classical sample name E-MTAB-5632:AO.IPC_input ERS1802831 SAMEA104143813 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143813 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:B.Tim_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual B.Tim organism part neoplasm phenotype basal sample name E-MTAB-5632:B.Tim_H3K27ac ERS1802832 SAMEA104143814 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143814 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:B.Tim_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual B.Tim organism part neoplasm phenotype basal sample name E-MTAB-5632:B.Tim_H3K27me3 ERS1802833 SAMEA104143815 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143815 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:B.Tim_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual B.Tim organism part neoplasm phenotype basal sample name E-MTAB-5632:B.Tim_H3K4me1 ERS1802834 SAMEA104143816 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143816 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:B.Tim_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual B.Tim organism part neoplasm phenotype basal sample name E-MTAB-5632:B.Tim_H3K4me3 ERS1802835 SAMEA104143817 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143817 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:B.Tim_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual B.Tim organism part neoplasm phenotype basal sample name E-MTAB-5632:B.Tim_H3K9me3 ERS1802836 SAMEA104143818 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143818 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:B.Tim_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual B.Tim organism part neoplasm phenotype basal sample name E-MTAB-5632:B.Tim_input ERS1802837 SAMEA104143819 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143819 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:D.IP_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual D.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:D.IP_H3K27ac ERS1802838 SAMEA104143820 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143820 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:D.IP_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual D.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:D.IP_H3K27me3 ERS1802839 SAMEA104143821 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143821 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:D.IP_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual D.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:D.IP_H3K4me1 ERS1802840 SAMEA104143822 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143822 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:D.IP_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual D.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:D.IP_H3K4me3 ERS1802841 SAMEA104143823 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143823 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:D.IP_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual D.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:D.IP_H3K9me3 ERS1802842 SAMEA104143824 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143824 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:D.IP_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual D.IP organism part neoplasm phenotype basal sample name E-MTAB-5632:D.IP_input ERS1802843 SAMEA104143825 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143825 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:foie8_H3K27ac broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual foei8 organism part neoplasm phenotype classical sample name E-MTAB-5632:foie8_H3K27ac ERS1802844 SAMEA104143826 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143826 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:foie8_H3K27me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual foei8 organism part neoplasm phenotype classical sample name E-MTAB-5632:foie8_H3K27me3 ERS1802845 SAMEA104143827 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143827 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:foie8_H3K4me1 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual foei8 organism part neoplasm phenotype classical sample name E-MTAB-5632:foie8_H3K4me1 ERS1802846 SAMEA104143828 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143828 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:foie8_H3K4me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual foei8 organism part neoplasm phenotype classical sample name E-MTAB-5632:foie8_H3K4me3 ERS1802847 SAMEA104143829 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143829 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:foie8_H3K9me3 broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual foei8 organism part neoplasm phenotype classical sample name E-MTAB-5632:foie8_H3K9me3 ERS1802848 SAMEA104143830 9606 Homo sapiens Protocols: PDAC tissue from surgical samples was fragmented, mixed with 100 μL of Matrigel and implanted with a trocar (10 gauge; Innovative Research of America, Sarasota, FL) in the subcutaneous right upper flank of an anesthetized and disinfected male NMRI-nude mouse. Samples obtained from EUS-FNA were mixed with 100 μL of Matrigel (BD Biosciences, Franklin Lakes, NJ) and injected in the upper right flank of a male nude mice (Swiss Nude Mouse Crl: NU(lco)-Foxn1nu; Charles River Laboratories, Wilmington, MA) for the first implantation. When xenografts reached 1 cm3, these were removed and passed to NMRI-nude mice in the same manner as the surgical samples. All animal experiments were conducted in accordance with institutional guidelines and were approved by the “Plateforme de Stabulation et d'Expérimentation Animale” (PSEA, Scientific Park of Luminy, Marseille). None No treatment was provide DNA was extracted using Blood & Cell culture DNA mini kit (Qiagen) following the manufacturer's instructions. ENA first public 2017-12-29 ENA last update 2017-06-28 External Id SAMEA104143830 INSDC center alias Mayo Clinic INSDC center name Mayo Clinic INSDC first public 2017-12-29T17:01:50Z INSDC last update 2017-06-28T10:06:43Z INSDC status public Submitter Id E-MTAB-5632:foie8_input broker name ArrayExpress common name human disease pancreatic adenocarcinoma growth condition xenograft in nude mouse individual foe8 organism part neoplasm phenotype classical sample name E-MTAB-5632:foie8_input